HSA
IART icon

Hussman Strategic Advisors’s Integra LifeSciences IART Stock Holding History

Hussman Strategic Advisors’s Portfolio IART Stock Details IART Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-168,000
Closed -$2.41M – 309
2025
Q3 		$2.41M Buy
+168,000
New +$2.3M 0.52% 62
2024
Q4 		– Sell
-147,000
Closed -$2.67M – 267
2024
Q3 		$2.67M Buy
+147,000
New +$3.41M 0.66% 44

Other funds holding IART

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
RCMNY
Rubric Capital Management (New York) New York $10.9B AUM 70.31% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Fuller & Thaler Asset Management
Fuller & Thaler Asset Management San Mateo, California $36.7B AUM 74.15% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
PCMI
Paradigm Capital Management Inc Albany, New York $3.67B AUM 121.12% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $150B AUM 40.08% 1-Year Est. Return

Hussman Strategic Advisors's IART Position: Q4 2025 in Review

Hussman Strategic Advisors sold out of Integra LifeSciences (IART) in Q4 2025, closing a stake of 168,000 shares — an estimated $2.41M sold.

Hussman Strategic Advisors first reported a position in IART in Q3 2024 and held it in 2 quarters. The position peaked at $2.67M in Q3 2024. 204 funds tracked by Wall St. Rank hold IART as of Q4 2025.

  • Hussman Strategic Advisors reported no remaining Integra LifeSciences position as of Q4 2025 after selling out during the quarter.
  • Hussman Strategic Advisors sold 168,000 Integra LifeSciences shares in Q4 2025, an estimated $2.41M.
  • Hussman Strategic Advisors first reported a position in Integra LifeSciences in Q3 2024 and held it in 2 quarters.
  • Hussman Strategic Advisors's Integra LifeSciences position peaked at $2.67M in Q3 2024.
  • 204 funds tracked by Wall St. Rank held Integra LifeSciences as of Q4 2025.

Based on Hussman Strategic Advisors's 13F filing for Q4 2025, filed 2 Feb 2026.